Skip to main content
Division of Cancer Prevention
Division of Cancer Prevention

Search form

Making cancer prevention possible

Main menu

  • Home
  • Major Programs
    • Cancer Prevention Fellowship Program (CPFP)
    • Early Detection Research Network (EDRN)
    • NCI Community Oncology Research Program (NCORP)
    • Alliance of Glycobiologists for Cancer Research
    • Barrett's Esophagus Translational Research Network (BETRNet)
    • Cancer Prevention Clinical Trials Network (CP-CTNet)
    • Cancer Prevention-Interception Targeted Agent Discovery Program (CAP-IT)
    • Cancer Screening Research Network (CSRN)
    • Cancer Treatment Tolerability Consortium
    • Consortium for Imaging and Biomarkers (CIB)
    • HIV/Cervical Cancer Prevention ‘CASCADE’ Clinical Trials Network
    • Liquid Biopsy Consortium
    • Lung Cancer Screening Image Library
    • Multi-Cancer Detection (MCD) Research
    • NCI Cervical Cancer ‘Last Mile’ Initiative
    • Pancreatic Cancer Detection Consortium (PCDC)
    • Phase 0/I/II Cancer Prevention Clinical Trials Program (Consortia)
    • PREVENT Cancer Preclinical Drug Development Program (PREVENT)
    • Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO)
    • Small Cell Lung Cancer (SCLC) Consortium
    • Supportive Care and Symptom Management
    • Translational and Basic Science Research in Early Lesions (TBEL) Program
    • Translational Liver Cancer (TLC) Consortium
    • US-Latin American-Caribbean HIV/HPV-Cancer Prevention Clinical Trials Network (ULACNet)
  • Research Groups
    • Biometry
    • Breast and Gynecologic Cancer
    • Cancer Biomarkers
    • Chemopreventive Agent Development
    • Community Oncology and Prevention Trials
    • Early Detection
    • Gastrointestinal and Other Cancers
    • Lung and Upper Aerodigestive Cancer
    • Nutritional Science
    • Prostate and Urologic Cancer
  • Clinical Trials
    • Clinical Trials Search
    • Landmark Trials
    • Clinical Trials Management
    • Why I Joined a Clinical Trial
  • Funding & Grants
    • Funding Opportunities
    • Funded Grants
    • Grantsmanship Resources
  • Resources
    • Publication Search
    • Biorepositories
    • Cancer Data Access System
  • News & Events
    • News
      • CP-CTNet Newsletter - September 2022
    • Blog
    • Meetings and Events
    • Videos and Webinars
    • Infographics
  • About DCP
    • Scientific Scope
    • Commemoration of the 50th Anniversary of the National Cancer Act
    • Director
    • DCP Leadership
    • History and Timeline
    • Historical Resources
    • Staff Directory

You are here

  1. Home
  2.   »  Research Groups
  3.   »  Chemopreventive Agent Development
  4.   »  Chemopreventive Agent Development Staff
  • Biometry
  • Breast and Gynecologic Cancer
  • Cancer Biomarkers
  • Chemopreventive Agent Development
    • About the Chemopreventive Agent Development Research Group
    • Active Grants
    • Cancer Prevention Clinical Trials Network (CP-CTNet)
    • Clinical Trials
    • Funding Opportunities
    • PREVENT Cancer Preclinical Drug Development Program (PREVENT)
    • Phase 0/I/II Cancer Prevention Clinical Trials Program (Consortia)
    • Publications
    • Staff
    • TEAG Forum: NCI Drug Development Resources: PREVENT and NExT Programs
  • Community Oncology and Prevention Trials
  • Early Detection
  • Gastrointestinal and Other Cancers
  • Lung and Upper Aerodigestive Cancer
  • Nutritional Science
  • Prostate and Urologic Cancer

Contact the Chemopreventive Agent Development Research Group

Phone: 240-276-7062
Fax: 240-276-7847

For Regular Mail

Chemopreventive Agent Development
Research Group, DCP, NCI
9609 Medical Center Drive
Bethesda, MD 20892-9787

For Courier Packages

Chemopreventive Agent Development
Research Group, DCP, NCI
9609 Medical Center Drive
Rockville, MD 20850

Chemopreventive Agent Development Staff

Photo Name Phonesort ascending Email Room
Marsha Greco Greco, Marsha 5E570
Kajal Biswas, Ph.D. Biswas, Kajal, Ph.D. biswask2@mail.nih.gov
Portrait of Winfred Malone, Ph.D., M.P.H. Malone, Winfred, Ph.D., M.P.H. 240-276-7096 malonew@mail.nih.gov 5E542
Portrait of Robert Shoemaker, Ph.D. Shoemaker, Robert, Ph.D. (chief) 240-276-7077 shoemakr@mail.nih.gov 5E454
Cholewa, Brian, Ph.D. 240-276-7077 cholewabd@mail.nih.gov 5E454
John Clifford Clifford, John, Ph.D. 240-276-6848 cliffordjl@mail.nih.gov 5E538
Asefa, Wosene 240-276-6422 asefaw@mail.nih.gov 5E514
Portrait of Altaf Mohammed, Ph.D. Mohammed, Altaf, Ph.D. 240-276-6082 mohammeda2@mail.nih.gov 5E540
Portrait of Vignesh Gunasekharan, Ph.D. Gunasekharan, Vignesh, Ph.D. 240-276-5814 gunasekharanv2@mail.nih.gov TBD
Portrait of Shizuko Sei, M.D. Sei, Shizuko, M.D. 240-276-5005 seis@mail.nih.gov 5E452
Portrait of Mark Miller, Ph.D. Miller, Mark Steven, Ph.D. (deputy chief) 240-276-5004 mark.miller5@nih.gov 5E542
Gupta, Shanker, Ph.D. 240-276-4800 guptasha@mail.nih.gov

View all Staff Members

Follow us at:

@NCIPrevention

@NCISymptomMgmt

@NCICastle

The National Cancer Institute

Policies

DCP Home

Contact DCP

Policies

Disclaimer Policy

Accessibility

FOIA

HHS Vulnerability Disclosure

NCI's PDQ® Evidence-based Summaries

Cancer Prevention

Screening/Detection/Testing for Cancer

Supportive and Palliative Care

General Information

Cancer Prevention, Specific Cancers, Clinical Trials

Cancer Screening Topics For People Who Have No Symptoms

Managing The Side Effects of Cancer and Its Treatment

Coping With Cancer

US Preventive Services Task Force Recommendations About Cancer

NIH COVID-19 Resources

U.S. Department of Health and Human Services  |  National Institutes of Health  |  National Cancer Institute  |  USA.gov

NIH…Turning Discovery Into Health®